Alder BioPharma Prices Offering At $177M
Alder BioPharmaceuticals Inc. said Thursday it had priced a follow-on offering of 6 million shares at $29.50 apiece, seeking to raise a total of $177 million to continue developing treatments for...To view the full article, register now.
Already a subscriber? Click here to view full article